Portuguese residents abroad who wish to enter Portugal by presenting proof of vaccination against covid-19 will only be able to do so if they have received one of the four vaccines approved by the European Union.

These vaccines, which are being administered in Portugal and in most EU Member States, are BioNTech-Pfizer, Moderna, AstraZeneca and Janssen (Johnson).

This means that Portuguese people who have received other vaccines in the countries where they live, such as Sinopharm or Sinovac (Chinese), Sputnik (Russian), Covaxin (Indian), Epivaccorona (Russian) or Soberana (Cuban), among others, and that want to enter Portugal upon proof of vaccination, they will not be able to do so.

These Portuguese may, however, enter Portugal upon presentation of a recovery certificate, if they have already contracted the infection.

According to the Directorate-General for Health (DGS), people recovered from covid-19, holders of a valid certificate, issued between the 11th and 180th days, after a laboratory test (positive), which confirmed the diagnosis, they will be able to enter Portugal.

Another possibility to enter Portugal is presenting a test certificate with a negative result.

The tests that are being accepted are the nucleic acid amplification test (TAAN) to detect the presence of SARS-CoV-2 RNA, whose sample has been collected within 72 hours prior to entering the national territory, and the rapid test of antigen (TRAg), for professional use, whose sample was collected within 48 hours before entry into Portugal.

On Thursday, Portugal approved the decree-law regulating the EU’s covid-19 digital certificate, proof of negative testing, vaccination or recovery from the disease, which will come into force in the 27 Member States in time for the summer and which could be used for travel.

The passport only includes vaccines approved by the EMA (European Medicines Agency): Pfizer/BioNTech, Moderna, AstraZeneca and Janssen.


Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more